CHI3L1 and interstitial lung disease: Further demonstrating the predictive potential of CHI3L1 as a biomarker for RA-ILD, ROC assessment revealed strong performance characteristics with AUC of 0.74 (95% CI, 0.68-0.81, p<0.001) (Figure 2A).